Affiliation:
1. Department of Otolaryngology – Head and Neck Surgery, School of Medicine, Stanford University, Palo Alto, CA
Abstract
Abstract
Chronic suppurative otitis media (CSOM) is a neglected disease that afflicts 330 million people worldwide and is the most common cause of permanent hearing loss among children in the developing world. Previously, we discovered that outer hair cell (OHC) loss occurred in the basal turn of the cochlea and that macrophages are the major immune cells associated with OHC loss in CSOM. Macrophage-associated cytokines are upregulated. Specifically, CCL-2, an important member of the MCP family, is elevated over time following middle ear infection. CCR2 is a common receptor of the MCP family and the unique receptor of CCL2. CCR2 knockout mice (CCR2−/−) have been used extensively in studies of monocyte activation in neurodegenerative diseases. In the present study, we investigated the effect of CCR2 deletion on the cochlear immune response and OHC survival in CSOM. The OHC survival rate was 84 ± 12.5% in the basal turn of CCR2+/+ CSOM cochleae, compared with was 63 ± 19.9% in the basal turn of CCR2−/− CSOM cochleae (p ≤ 0.05). Macrophage numbers were significantly reduced in CCR2−/− CSOM cochleae compared with CCR2+/+ CSOM cochleae (p ≤ 0.001). In addition, CCL7 was upregulated, whereas IL-33 was downregulated, in CCR2−/− CSOM cochleae. Finally, the permeability of the blood–labyrinth barrier in the stria vascularis remained unchanged in CCR2−/− CSOM compared with CCR2+/+ CSOM. Taken together, the data suggest that CCR2 plays a protective role through cochlear macrophages in the CSOM cochlea.
Publisher
The American Association of Immunologists
Reference36 articles.
1. The global burden of disease in 1990: summary results, sensitivity analysis and future directions;Murray;Bull. World Health Organ.,1994
2. Burden of disease caused by otitis media: systematic review and global estimates;Monasta;PLoS One,2012
3. Biofilms: microbial life on surfaces;Donlan;Emerg. Infect. Dis.,2002
4. Design and assessment of anti-biofilm peptides: steps toward clinical application;Dostert;J. Innate Immun.,2019
5. Bacterial resistance in biofilm-associated bacteria;Venkatesan;Future Microbiol.,2015